2Satoh M, Chan EKL, Sobel ES, et al. Clinical implication of au- toantibodies in patients with systemic rheumatic diseases [ J]. Exp Rev Clin Immunol,2007,3 ( 5 ) :721-738.
3Satoh M, Vazquez-Del Mercado M, Chan EK. Clincal interpretation of antinuclear antibody tests in systemic rheumatic diseases[ J]. Mod Rheumatol, 2009,19 ( 3 ) :219-228.
4Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1982,25 ( 11 ) : 1271-1277.
5Kang SY, Lee WI. Clinical significance of dense fine speckled pat- tern in anti-nuclear antibody test using indirect immunofluorescence method[ J]. Korean J Lab Med, 2009,29(2) : 145-151.
6Ghirardello A, Doria A, Zampieri S, et al. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tis- sue diseases: their specificity for SLE and association with IgG anti- cardiolipin antibodies[J]. Ann Rheum Dis, 2000,59(12) :975-981.
8Jolly M, Smaron M, olsen utset T,et al. M. Are isolated antinucle olar antibodies a marker of scleroderma[ J ]. J clin Rheumatol, 2003,9 (5) : 291-295.
